Delivery Order SPE2DB22D2211-SPE2DB24FPHA0

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Nystatin 100,000 unit/mL suspension in 473mL containers. The Delivery Order, awarded on July 15, 2024, has a firm fixed price of $1,182.96 and a completion date of July 16, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Nystatin 100,000 unit/mL suspension in 473 mL bottles. The contract is a Firm Fixed Price Delivery Order valued at $3,415.98, with a period of performance through September 13, 2024. There is no set-aside designation for this award. Amerisourcebergen, through its Corporate Office division, will provide these pharmaceutical...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,783.50 firm-fixed-price contract covers the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The $1,991.25 firm fixed-price contract is for the provision of pharmaceutical products and medical supplies, including a wide range of prescription medications, over-the-counter drugs, and medical devices and supplies. The award is associated with a larger Indefinite Delivery Contract (IDC) held...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for $115,033.56. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999 that covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes specialty medications, brand-name and generic drugs, vaccines,...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,824.12 firm fixed price award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,905.50 firm fixed price contract is for the supply of various pharmaceutical products and medical supplies, such as specialty medications, brand-name and generic drugs, vaccines, and medical equipment. This award is not set aside for any specific business category. The award is associated with a larger Indefinite Delivery Contract...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The $1,821.60 firm fixed-price contract provides a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. This award is associated with a...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,865.12 firm fixed price contract has a period of performance ending on February 24, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,064.72 firm fixed price award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPHA0
    Delivery Order

This is a delivery order award to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,697.92 firm fixed-price contract is for the supply of Nystatin 100,000 Unit/mL Suspension in 473 mL bottles. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a wide range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide.

Generated 12/4/24, 9:36 AM